CompletedPhase 2NCT01377974
Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis
Studying Leishmaniasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Brasilia University Hospital
- Principal Investigator
- Juliana SF Silva, MDUniversity of Brasilia
- Intervention
- Miltefosine(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 12-90 years · All sexes
- Timeline
- 2009 – 2014
Study locations (1)
- Brasilia University Hospital, Brasília, Federal District, Brazil
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01377974 on ClinicalTrials.govOther trials for Leishmaniasis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07487350Recurrent Visceral Leishmaniasis in HIV Co-InfectionInstitute of Tropical Medicine, Belgium
- RECRUITINGPHASE3NCT06822478Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II.Universidad de Antioquia
- ACTIVE NOT RECRUITINGNANCT06983665Human Bioequivalence Study of Liposomal Amphotericin B for InjectionSichuan Huiyu Pharmaceutical Co., Ltd
- RECRUITINGPHASE2NCT06798415Intralesional Injection of Metronidazole for the Management of Cutaneous LeishmaniasisHayder Adnan Fawzi
- RECRUITINGPHASE2NCT06797544Intralesional Injection of Levofloxacin for the Management of Cutaneous LeishmaniasisHayder Adnan Fawzi
- RECRUITINGPHASE2NCT06798402Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium StibogluconateAl-Mustafa University College
- RECRUITINGPHASE2NCT06550609Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis with Inhaled Pentamidine Plus Oral MiltefosineFundacion Nacional de Dermatologia
- RECRUITINGNCT07504757LEISH-PED: Study on Leishmaniasis in ChildrenMeyer Children's Hospital IRCCS